Microsoft has ended support for its pre-IE11 browsers as of January 2016 and will be discontinuing IE11 support in August 2021.

If you are seeing this message, you are viewing the site on one of these unsupported browsers. We only support the recent versions of major browsers such as Chrome, Firefox, Safari, and Edge.

Thank you.

(click to close and continue using this browser)

Sign InDues Join Donate Privacy Contact Search
Home News Impact of CMS Step Therapy Reform on Patient Access


Impact of CMS Step Therapy Reform on Patient Access

posted: June 24, 2019

Survey.jpgThe Academy of Physicians in Clinical Research (APCR) is the exclusive organization representing the physician research community in the American Medical Association (AMA). APCR helps guide national policy and comments on issues impacting your practices. Recently, APCR had the opportunity to work with Health Strategies Insights to conduct a survey on the impacts of step therapy reform on patient access. With the Centers of Medicare and Medicaid Services (CMS) recently finalizing its proposal to give Medicare Advantage plans the option of applying step therapy for Part B drugs, the APCR decided to get a pulse on the impacts to our community.

The survey, conducted by HSI, was administered to fifty physicians — including some APCR members — who administer Part B drugs in their offices. Based on the results of the survey, an infographic was created to be shared with our community. As President of APCR, I’m pleased to have had this opportunity to conduct this research and demonstrate our organization’s value in advocating on behalf of physicians.

Cara East, MD, FAPCR
President, APCR